1. Fourier, Carmen, Ran, Caroline, Steinberg, Anna, Waldenlind, Elisabet, Belin, Andrea Carmine. 2019. Analysis of HCRTR2 Gene Variants and Cluster Headache in Sweden. In Headache, 59, 410-417. doi:10.1111/head.13462. https://pubmed.ncbi.nlm.nih.gov/30652302/
2. Yang, Jiao, Yu, Si-Yi, Yang, Jie, Liang, Fan-Rong, Lv, Zheng-Tao. 2020. No Association Between G1246A Polymorphism in HCRTR2 Gene and Risk of Cluster Headache: Evidence From an Updated Meta-Analysis of Observational Studies. In Frontiers in genetics, 11, 560517. doi:10.3389/fgene.2020.560517. https://pubmed.ncbi.nlm.nih.gov/33343621/
3. Firouzabadi, Negar, Navabzadeh, Niloofar, Moghimi-Sarani, Ebrahim, Haghnegahdar, Maral. 2020. Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients. In Neuropsychiatric disease and treatment, 16, 1121-1128. doi:10.2147/NDT.S250141. https://pubmed.ncbi.nlm.nih.gov/32440126/
4. Dashti, Hassan S, Daghlas, Iyas, Lane, Jacqueline M, Garaulet, Marta, Saxena, Richa. 2021. Genetic determinants of daytime napping and effects on cardiometabolic health. In Nature communications, 12, 900. doi:10.1038/s41467-020-20585-3. https://pubmed.ncbi.nlm.nih.gov/33568662/
5. Gallone, Salvatore, Boschi, Silvia, Rubino, Elisa, Pinessi, Lorenzo, Rainero, Innocenzo. 2014. Is HCRTR2 a genetic risk factor for Alzheimer's disease? In Dementia and geriatric cognitive disorders, 38, 245-53. doi:10.1159/000359964. https://pubmed.ncbi.nlm.nih.gov/24969517/